Urine Drug Testing to help in Early Stage of Opioid Use Treatment

Urine Drug Testing to help in Early Stage of Opioid Use Treatment

Opioid use disorders have assumed epidemic proportions, especially in developed countries such as the U.S. Success in treatment and prevention in primary care settings, such as in office-based interventions, are beset with the lack of truthful self-reporting substance use. And there can be several reasons for this ranging from the fear of early discharge from the program and marked embarrassment of relapse they may face among peers. This may result in successful monitoring of substances use of opioid and cocaine off the track. A recent study has found urine drug testing (UDT) to be a useful tool in successful monitoring of patients in their treatment visits in primary care. The authors of the study revealed that the rate of self-reported substance use increased proportionately with the rate of positive clinical result of urine tests.

The study was performed by a team of researchers from the Boston University School of Medicine in collaboration with Boston Medical Center. The details of the study are published in Drug and Alcohol Dependence in November 2018.

Patients refrained from Using Opioid and Cocaine Early in Treatment

There has been a lack of reliable data correlating the frequency of self-reported substance use in opioid use disorders and UDTs findings. Early in the programs, the researchers found that patients refrained from self-reporting illicit use of cocaine and opioids in early stages of treatment. But over the course of period, they had started making truthful revelations, thus stressing on the growing level of trust between them and caregiver in the treatment program.

Findings to support Effective Office-Based Intervention Programs

The authors of the study, thus, called for less frequent UDTs as the patients make noticeable headway in their recovery. The findings of the study shed light on guidelines for effective short- and long-term policies in primary care interventions in opioid use disorders. Additionally, this is likely to pave way to setting optimal protocols for UDT in office-based intervention programs in the coming years.

Leave a Reply

Your email address will not be published. Required fields are marked *